Disposable Noninvasive Ventilation Masks Segment to Lead Noninvasive Ventilation Masks Market During 2023-2031

According to our new research study on "Noninvasive Ventilation Masks Market Forecast to 2031 - Global Analysis - by Product, Application, and End User," the market is expected to grow from US$ 2.05 billion in 2023 to US$ 3.25 billion by 2031; it is anticipated to record a CAGR of 5.9% from 2023 to 2031. The noninvasive ventilation masks market report emphasizes the trends prevalent in the global market, along with drivers and deterrents affecting its growth. The market report emphasizes trends prevalent in the market, along with drivers and deterrents affecting its growth. NIV masks are used in medical settings to provide respiratory support without the need for intubation. They are typically used for patients with conditions such as COPD, pneumonia, or respiratory failure. NIV masks deliver positive pressure to help patients breathe more easily, improving oxygenation and reducing the work of breathing. They come in various styles, such as full face masks or nasal masks, depending on the patient's needs and comfort.

The increasing prevalence of respiratory ailments and the rising shift toward home healthcare are contributing to the noninvasive ventilation masks market growth. However, side effects associated with NIV masks hamper the market growth. Nevertheless, technological advancements in noninvasive ventilation masks are expected to bring new noninvasive ventilation masks market trends in the coming years.

Rising Inclination Toward Home Healthcare Propels Market Growth

A shift from long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in a better, consistent, and timely interaction between patient and doctor owing to the cloud and mobility-driven medical devices. The COVID-19 outbreak triggered home healthcare's importance due to limited hospital bed capacity and a scarcity of skilled healthcare professionals. With the help of home healthcare, healthcare professionals can monitor patient's vitals remotely and avoid hospital admissions.

Additionally, noninvasive ventilation masks are becoming increasingly popular and expanding market opportunities by spurring innovation. Earlier diagnosis and treatment are being made possible by growing awareness campaigns about respiratory disorders such as COPD, sleep apnea, and others. The increased prescription and usage of NIV masks for disease management results from greater awareness among patients and healthcare professionals. Thus, emerging awareness of early diagnosis is likely to drive the adoption of NIV masks and create significant opportunities in the market. Moreover, respiratory illnesses are becoming more common in emerging economies, particularly in Asia Pacific, Latin America, and the Middle East, due to pollution, urbanization, and lifestyle changes. The noninvasive therapies are becoming widely known in these areas, owing to which the use of NIV masks is likely to continue to propel during the forecast period.

The product segment of the noninvasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held a larger share of the noninvasive ventilation masks market in 2023. Disposable noninvasive ventilation masks are single-use masks and are disposed off to reduce the risk of cross-contamination. These masks are used to maintain or improve arterial oxygenation to manage hypoxemia in high-risk patients. For instance, the Janus ventilation mask by Biomedical SRL is a full-face mask that provides oxygen during sedation without tracheal intubation. It features an airtight port for transesophageal echocardiography inspection and allows for NIV in cases of acute respiratory failure. The mask can be opened and removed without disturbing the instrument if needed. Therefore, the rising requirement for high-quality disposable solutions from patients who need NIV therapy propels the demand for single-use/disposable NIV masks. Market players such as Hamilton Medical, Philips, and Intersurgical offer a wide range of single-use NIV masks for both pediatric and adult patients. Hamilton's Pulmodyne BiTrac masks have adjustable headgear and easy-to-use clips and are tailored as one-size-fits-all.

Based on application, the market is segmented into obstructive sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held the largest share of the noninvasive ventilation masks market in 2023.

Based on end user, the market is segmented into hospitals and clinics, homecare, and others. The hospitals and clinics segment held the largest share of the noninvasive ventilation masks market in 2023.

As per the company news, few of the developments in the market are as follows:

- In August 2024, A leading pediatric hospital in the United States partnered with Sleepnet Corporation to introduce the Mini Me 2 Non-Invasive Ventilation (NIV) mask. This use case explores the motivations behind this collaboration, the implementation process, and the outcomes achieved.

- In January 2024, Intersurgical acquired Pulmodyne, a USA and Malaysia-based manufacturer specializing in airway and respiratory products. The acquisition will expand Intersurgical's product range, strengthen its presence in the USA market, and increase sales of Pulmodyne products globally.


Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com